Trial data reveals potential new treatment for pulmonary fibrosis patients
The data from the 12 week trial showed phosphodiesterase 4B…
The data from the 12 week trial showed phosphodiesterase 4B (PDE4B) inhibitor BI 1015550 showed a reduction in the rate of lung function decline in patients with idiopathic pulmonary fibrosis (IPF).